Compare TOUR & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOUR | ZTEK |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Transportation Services | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.1M | 68.8M |
| IPO Year | 2014 | 2022 |
| Metric | TOUR | ZTEK |
|---|---|---|
| Price | $0.74 | $0.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 126.2K | 69.5K |
| Earning Date | 03-05-2026 | 02-18-2026 |
| Dividend Yield | ★ 4.86% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.30 | N/A |
| Revenue Next Year | $14.00 | N/A |
| P/E Ratio | $87.34 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.56 | $0.46 |
| 52 Week High | $1.01 | $1.84 |
| Indicator | TOUR | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 55.95 | 32.93 |
| Support Level | $0.74 | N/A |
| Resistance Level | $0.79 | $0.57 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 62.76 | 24.11 |
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.